Chronic myeloid leukemia highlights from ASH 2025 include data on nilotinib vs imatinib, asciminib in second line, somatic ...

A study from Washington University School of Medicine in St. Louis suggests a strategy for preventing a chronic, slow-growing type of blood cancer from progressing to an aggressive form of leukemia.

Pirtobrutinib (Jaypirca®), a first-in-class noncovalent Bruton tyrosine kinase (BTK) inhibitor, has been approved by the FDA ...

"When significant subsets of patients, whether of a certain race, sex, or others, are not included in sufficient numbers in clinical trials, the results cannot be assumed to represent or be applicable ...

The impact of Covid-19 pandemic on breast cancer multidisciplinary management at the Vall d'Hebron University Hospital. Nutrition and head-neck cancer: A prospective observational study in patients ...

The narrative highlights the importance of creating intentional spaces of silence and mindfulness amidst the chaos of chronic ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

Any cancer diagnosis—or just the idea of one—is scary. Leukemia can be especially scary because it's a bit confusing. Unlike liver or breast cancer, the word doesn't specify where the cancer ...